10. Teladoc ties up telehealth provider InTouch Health

Teladoc account
Teladoc saw InTouch as a way to build itself into the prime choice for health systems looking for a one-stop shop in a virtual care partner. (Teladoc)

Deal value: $600 million
Announced: January 12, 2020
Closed: July 1, 2020

Bookending our list is Teladoc once again, with its $600 million acquisition of InTouch Health spanning the first half of last year. 

First announced in mid-January 2020, the deal predated the international spread and rise of COVID-19, which would send demand rocketing for virtual doctor visits in the face of social distancing measures, stay-at-home orders and flooded hospitals. Teladoc would see its traffic accelerate by 50% week-over-week before the end of that March and claim a 69% boost in the network’s total membership by the end of the quarter.

InTouch, meanwhile, served as a provider of enterprise solutions for hospitals, which Teladoc saw as a route to build itself into the prime choice for health systems looking for a one-stop shop in a virtual care partner. At the time, InTouch connected more than 3,600 global locations, with programs supporting more than 40 clinical areas.

RELATED: Teladoc to take over Livongo in $18.5B digital health deal

Doing so included providing purpose-built telehealth devices for exam suites and operating rooms—such as wheeled robots equipped with screens, video cameras, and peripherals for mimicking in-person care and diagnosing patients while being piloted by remote physicians or specialists.

The takeover of this portfolio set the stage for a patent infringement lawsuit, launched not long after the deal closed. Teladoc sued one of its main competitors, Amwell, over claims related to its digital stethoscopes and connected telemedicine carts.

RELATED: Teladoc accuses Amwell of patent infringement as competition in telehealth market heats up

But it wasn’t the first time the two had met in court over intellectual property. In 2015, then known as American Well, Amwell sued Teladoc shortly before its IPO over patents on backend computer systems that matched up patients’ requests for care with available providers. However, a federal judge later threw out the case, finding those claims to be too broad and too abstract to be enforced.

Teladoc would later return the favor, accusing the company of infringing its patents just days before Amwell went public with an outsized $742 million offering. The latest lawsuit continues, with Teladoc requesting a jury trial.

RELATED: Teladoc to pilot CGMs in Type 2 diabetes as Dexcom eyes new growth market

Meanwhile, with Livongo and InTouch in hand, Teladoc saw just shy of $1.1 billion in 2020 revenue—nearly double the $553 million it made the year before. The company also expects that trajectory to continue, with $1.95 billion to $2.0 billion in sales projected for 2021, generated through 12 to 13 million virtual visits.

10. Teladoc ties up telehealth provider InTouch Health